Authors

Addressing resident burnout starts with program’s culture

"I was overcome by the sinking notion that my career ambitions were regressing from thriving to surviving-a sentiment I know isn’t unique to my training. What may be unique, however, is how my program responded to increasingly evident signs of resident burnout," says James Anaissie, MD.

New J-code supports reimbursement for gemcitabine intravesical system

“Once we actually get a J code for a medication, it really solidifies the amount of reimbursement that's going to occur,” says Jonathan Rubenstein, MD.

Robotic ureteroscopy: The future of stone management?

Advances in robotic URS will help target stones and reduce ionizing radiation.

Robotic ureteroscopy: The future of stone management?

Advances in robotic URS will help target stones and reduce ionizing radiation.

Upper tract transitional cell carcinoma: Diagnostic and therapeutic considerations

Determining grade of disease is important, as nephron-sparing approaches may be feasible.

The case for transperineal prostate biopsy vs. the transrectal approach

Reduced infection rate may drive increased use of the transperineal approach.

The case for transperineal prostate biopsy vs. the transrectal approach

Reduced infection rate may drive increased use of the transperineal approach.

An end to the decline in prostate cancer mortality

"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.

An end to the decline in prostate cancer mortality

"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.

Bicycle riding: Good or bad for men’s health?

Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.

Bicycle riding: Good or bad for men’s health?

Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.

Updated AUA guidelines on BPH: What urologists need to know

The updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.

Updated AUA guidelines on BPH: What urologists need to know

The updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.

Telemedicine in urology: A crash course during the COVID-19 pandemic

"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.

Telemedicine in urology: A crash course during the COVID-19 pandemic

"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.

John Gore, MD, on bladder preservation in muscle–invasive bladder cancer

“In this well-selected patient population, it is possible to treat with systemic therapy alone," says John L. Gore, MD, MS.

MRI/TRUS fusion-guided biopsy using UroNav

Pinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.

MRI/TRUS fusion-guided biopsy using UroNav

Pinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.

Arvin George, MD, highlights VAPOR 2 trial of thermal water therapy for prostate cancer

Arvin K. George, MD, discusses the unique design of the VAPOR 2 trial and the key findings from the first 110 patients enrolled.

New developments may change treatment of OAB

"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.

New developments may change treatment of OAB

"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.

Artificial intelligence is the new ghost author in urological research

“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.

Acute-care urology during the pandemic: Lessons learned

"The goal of this narrative is to share details and lessons learned during our on-call urology coverage in the midst of the current pandemic so we can help others by informing planning," write Alexander Small, MD, and Rich Matulewicz, MD.

Making Sense of the Reintervention Rate for BPH

Addition to avelumab to best supportive care after firstline chemo improves OS in advanced urothelial Ca

Avelumab (Bavencio) as a maintenance treatment after chemotherapy significantly extended overall survival in patients with advanced urothelial cancer, according to findings from thephase III JAVELIN Bladder 100 trial.

Management of UTUC using a kidney-sparing approach

Advances in endourology have made kidney-sparing treatments a viable treatment option.

Robotics in GU oncology: Current status, future directions

The breadth of applications will widen as the number of new platforms grows, according Joshua Calvert, MD, MPH.